Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 3/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12889483 | 1.00 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1734334 | 0.98 | SLC1A3 (0.43) | SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15196136 | 0.85 | — | — | |
| SCHEMBL14611342 | 0.80 | — | — | |
| SCHEMBL4071619 | 0.80 | — | — | |
| SCHEMBL4071620 | 0.80 | — | — | |
| SCHEMBL5496473 | 0.80 | PDF (0.48) | — | |
| SCHEMBL5496476 | 0.80 | PDF (0.48) | — | |
| SCHEMBL5659393 | 0.79 | — | — | |
| SCHEMBL5657930 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020165167-A1 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2002-11-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165167-A1 | Antibacterial agents | CBR1, CBR3, SIGMAR1 | SLC1A3 3707/4885SLC1A2 3874/4885SLC1A1 2748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.